直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Michael J. Flibbert
Partner
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4493
michael.flibbert@finnegan.com michael.flibbert@finnegan.com

Michael J. Flibbert

Partner

  • +1 202 408 4493 +1 202 408 4493
  • michael.flibbert@finnegan.com michael.flibbert@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

With more than 20 years of patent litigation experience, Mike Flibbert serves as lead counsel in inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), district court litigations, and appeals at the U.S. Court of Appeals for the Federal Circuit.

Mike represents clients in patent cases involving pharmaceuticals, biotechnology, chemistry, chemical engineering, agriculture, and materials science. He has particular experience representing pharmaceutical patent holders in litigations arising under the Hatch-Waxman Act. He previously served as practice group leader for the firm’s chemical and metallurgical practice group.

Mike counsels clients on patent issues, including infringement, validity, enforceability, appeals, and remedies. He also has experience in U.S. International Trade Commission (ITC) actions, patent prosecution, antitrust law, licensing, and alternative dispute resolution.
 

Mike lectures in the United States and abroad on patent law topics, including PTAB practice and the America Invents Act (AIA). He has been recognized by Intellectual Asset Management (IAM) for his practice in the DC region as well as by The Legal 500 U.S. for his contributions to post-grant proceedings and other practice areas.

Et Cetera

  • Capital Pro Bono Honor Roll, 2018-2020.

Experience

E. I. du Pont de Nemours v. Monsanto Technology

Served as DuPont’s lead counsel in Federal Circuit appeal from Board decision in inter partes reexamination proceeding relating to transgenic soybean technology, leading to affirmance of the decision in DuPont’s favor.

17-1032, -1098, Fed. Cir.

E. I. du Pont de Nemours v. Synvina C.V.

Served as DuPont’s and ADM’s lead counsel in a successful Federal Circuit appeal from an IPR proceeding, resulting in reversal of the PTAB’s decision and invalidation of all challenged claims of Synvina’s patent directed to production of 2,5-furan dicarboxylic acid.

17-1977, Fed. Cir.

Danisco US Inc. v. Novozymes A/S

Served as Danisco’s lead counsel in IPR challenge to Novozymes patent relating to process of recovering oil during ethanol production, leading to favorable institution decision followed by Novozymes’ request for adverse judgment.

IPR2019-01010, PTAB

Coalition for Affordable Drugs V LLC v. Biogen MA Inc.

Served as Biogen's lead counsel in three IPRs relating to the MS drug Tecfidera®, leading to non-institution decisions in the first two proceedings and a final decision confirming patentability in the third proceeding.  

IPR2015-01086, -01136, -01993, PTAB, Judges Gardener-Lane, Katz, Schafer

Lannett Holdings, Inc. v. AstraZeneca AB

Served as patent owner AstraZeneca's lead counsel in two IPRs relating to Zomig® Nasal Spray, leading to non-institution decisions in both proceedings. 

IPR2015-01629, -01630, PTAB, Judges Paulraj, Snedden, Yang

REG Synthetic Fuels, LLC v. Neste Oil Oyj

Served as patent owner Neste Oil's lead counsel in two IPRs relating to biofuels: one settled and the other resulted in grant of motion to amend the patent.

IPR2013-00178; IPR2014-00192, PTAB

More

Insights

At the PTAB Blog

Finnegan Attorneys Author the Third Edition of The Practitioner’s Guide to Trials Before the Patent Trial and Appeal Board Finnegan Attorneys Author the Third Edition of The Practitioner’s Guide to Trials Before the Patent Trial and Appeal Board

November 28, 2022

Books

The Practitioner's Guide to Trials Before the Patent Trial and Appeal Board, Third Edition The Practitioner's Guide to Trials Before the Patent Trial and Appeal Board, Third Edition

September 2022

Federal Circuit IP Blog

Podcast Series: Last Month at the Federal Circuit - April 2021 Podcast Series: Last Month at the Federal Circuit - April 2021

May 7, 2021

Download

Podcasts

April 2021 - Last Month at the Federal Circuit Podcast Series

April 2021 - Last Month at the Federal Circuit Podcast Series April 2021 - Last Month at the Federal Circuit Podcast Series

May 6, 2021

Download

Articles

Standing Requirements for Appealing PTAB Decisions: Recent Developments Standing Requirements for Appealing PTAB Decisions: Recent Developments

July 16, 2020

Westlaw Journal Intellectual Property
Download

Articles

Against the Odds—Prevailing on IPR Grounds Without Satisfying the ‘Reasonable Likelihood’ Standard Against the Odds—Prevailing on IPR Grounds Without Satisfying the ‘Reasonable Likelihood’ Standard

October 23, 2019

Bloomberg Law
More

Professional Recognition

"Flibbert has argued in many contentious forums, but his best asset is his ability to litigate in complex Hatch-Waxman disputes."

Intellectual Asset Management Patent 1000

“Michael Flibbert’s advocacy and technical talents are frequently on show at the PTAB, as well as in ITC matters and Hatch-Waxman Act litigation.”

Intellectual Asset Management Patent 1000

“Flibbert has been fending off inter partes review petitions filed by biosimilar drug makers with a striking rate of success…”

Intellectual Asset Management Patent 1000

“Flibbert is distinguished by his post-grant expertise and vital contribution to one of the best PTAB practices in the country.”

Intellectual Asset Management Patent 1000

"Flibbert has argued in many contentious forums, but his best asset is his ability to litigate in complex Hatch-Waxman disputes."

Intellectual Asset Management Patent 1000

“Michael Flibbert’s advocacy and technical talents are frequently on show at the PTAB, as well as in ITC matters and Hatch-Waxman Act litigation.”

Intellectual Asset Management Patent 1000

“Flibbert has been fending off inter partes review petitions filed by biosimilar drug makers with a striking rate of success…”

Intellectual Asset Management Patent 1000

“Flibbert is distinguished by his post-grant expertise and vital contribution to one of the best PTAB practices in the country.”

Intellectual Asset Management Patent 1000

News

Award/Ranking

50 Finnegan Attorneys Ranked in the 2025 IAM Patent 1000

50 Finnegan Attorneys Ranked in the 2025 IAM Patent 1000

June 2, 2025

Intellectual Asset Management (IAM)

Award/Ranking

46 Finnegan Attorneys Ranked in 2024 IAM Patent 1000

46 Finnegan Attorneys Ranked in 2024 IAM Patent 1000

June 6, 2024

Intellectual Asset Management (IAM)

Press Release

32 Finnegan Attorneys Recognized by Best Lawyers

32 Finnegan Attorneys Recognized by Best Lawyers

August 17, 2023

Best Lawyers

Award/Ranking

54 Finnegan Attorneys Named to 2022 Capital Pro Bono Honor Roll 54 Finnegan Attorneys Named to 2022 Capital Pro Bono Honor Roll

July 21, 2023

Press Release

Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked

June 30, 2023

Intellectual Asset Management (IAM)

Press Release

29 Finnegan Attorneys Ranked by Best Lawyers

29 Finnegan Attorneys Ranked by Best Lawyers

August 18, 2022

U.S. News—Best Lawyers
More

Professional Activities

  • American Bar Association
  • American Intellectual Property Law Association
  • District of Columbia Bar Association
  • Federal Circuit Bar Association
  • Order of the Coif
Admissions and Education

Admissions

  • U.S. Patent and Trademark Office
  • District of Columbia
  • Virginia
  • U.S. Court of Appeals, Federal Circuit
  • Supreme Court of the United States

Education

George Washington University Law School
J.D., with honors, 1994
Georgetown University
B.S., Chemistry, 1986

Clerkships

  • U.S. Court of Appeals, Federal Circuit

Michael's Practices

Appeals, Issues, and Legal Strategy
Appeals from the PTAB
Federal Circuit and Supreme Court Appeals
Diligence, Licensing, and Opinions
Licensing, Pooling, and Other Transactions
Opinions and Counseling
Global IP Enforcement, Litigation, and Trials
Branded Hatch-Waxman (ANDA) Litigation and Trials
ITC Section 337 Investigations and Trials
Patent Litigation and Trials
Pretrial Strategies
Patent Office Invalidation Proceedings
PTAB Invalidation Proceedings: IPR and PGR
Prosecution and Portfolio Management
Appeals to the PTAB
Patent Drafting and Prosecution

Michael's Industries

Chemicals, Industrials, and Materials
Chemical
Energy
Clean Energy and Renewables
Oil and Gas
Life Sciences
Biotechnology
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP